Active substance
Results for the substance peginterferon beta 1a
4 results
About this active substance
Peginterferon beta-1a is a medication used in the treatment of relapsing multiple sclerosis. It works by modulating the immune response and reducing inflammation, helping to decrease the frequency of relapses and slow disease progression.
The medication is administered subcutaneously, as directed by a doctor, usually once every two weeks. It is important for patients to follow the treatment regimen and inform the doctor of any unusual symptoms.
Patients should be aware of potential side effects, such as injection site reactions, flu-like symptoms, or fatigue. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, flu-like symptoms, and fatigue. In rare cases, severe reactions such as depression or liver disorders may occur. Patients should be informed of these risks before use.
The medication is administered subcutaneously, as directed by a doctor, usually once every two weeks. It is important for patients to follow the treatment regimen and inform the doctor of any unusual symptoms.
Patients should be aware of potential side effects, such as injection site reactions, flu-like symptoms, or fatigue. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, flu-like symptoms, and fatigue. In rare cases, severe reactions such as depression or liver disorders may occur. Patients should be informed of these risks before use.
-
-
PLEGRIDY 63mcg/94mcg solution for injection in pre-filled pen BIOGEN ORIGINAL MEDICINE
-
PLEGRIDY 63mcg/94mcg solution for injection in pre-filled syringe BIOGEN ORIGINAL MEDICINE
-
PLEGRIDY 125mcg solution for injection in pre-filled syringe BIOGEN ORIGINAL MEDICINE